Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Entry, fate and degradation of DNA nanocages in mammalian cells: a matter of receptors.

Raniolo S, Vindigni G, Unida V, Ottaviani A, Romano E, Desideri A, Biocca S.

Nanoscale. 2018 Jul 5;10(25):12078-12086. doi: 10.1039/c8nr02411a.

PMID:
29911715
2.

Selective targeting and degradation of doxorubicin-loaded folate-functionalized DNA nanocages.

Raniolo S, Vindigni G, Ottaviani A, Unida V, Iacovelli F, Manetto A, Figini M, Stella L, Desideri A, Biocca S.

Nanomedicine. 2018 Feb 17;14(4):1181-1190. doi: 10.1016/j.nano.2018.02.002. [Epub ahead of print]

PMID:
29458213
3.

Membrane cholesterol depletion in cortical neurons highlights altered NMDA receptor functionality in a mouse model of amyotrophic lateral sclerosis.

Antonini A, Caioli S, Saba L, Vindigni G, Biocca S, Canu N, Zona C.

Biochim Biophys Acta Mol Basis Dis. 2018 Feb;1864(2):509-519. doi: 10.1016/j.bbadis.2017.11.008. Epub 2017 Nov 24.

PMID:
29154925
4.

DNA hairpins promote temperature controlled cargo encapsulation in a truncated octahedral nanocage structure family.

Franch O, Iacovelli F, Falconi M, Juul S, Ottaviani A, Benvenuti C, Biocca S, Ho YP, Knudsen BR, Desideri A.

Nanoscale. 2016 Jul 21;8(27):13333-41. doi: 10.1039/c6nr01806h. Epub 2016 Jun 24.

PMID:
27341703
5.

Receptor-Mediated Entry of Pristine Octahedral DNA Nanocages in Mammalian Cells.

Vindigni G, Raniolo S, Ottaviani A, Falconi M, Franch O, Knudsen BR, Desideri A, Biocca S.

ACS Nano. 2016 Jun 28;10(6):5971-9. doi: 10.1021/acsnano.6b01402. Epub 2016 May 26.

PMID:
27214742
6.

The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancer.

Murdocca M, Mango R, Pucci S, Biocca S, Testa B, Capuano R, Paolesse R, Sanchez M, Orlandi A, di Natale C, Novelli G, Sangiuolo F.

Oncotarget. 2016 Mar 22;7(12):14765-80. doi: 10.18632/oncotarget.7430.

7.

Membrane Cholesterol Modulates LOX-1 Shedding in Endothelial Cells.

Gioia M, Vindigni G, Testa B, Raniolo S, Fasciglione GF, Coletta M, Biocca S.

PLoS One. 2015 Oct 23;10(10):e0141270. doi: 10.1371/journal.pone.0141270. eCollection 2015.

8.

Intrabody-mediated diverting of HP1β to the cytoplasm induces co-aggregation of H3-H4 histones and lamin-B receptor.

Cardinale A, Filesi I, Singh PB, Biocca S.

Exp Cell Res. 2015 Oct 15;338(1):70-81. doi: 10.1016/j.yexcr.2015.09.006. Epub 2015 Sep 10.

PMID:
26364738
9.

Molecular mechanism of statin-mediated LOX-1 inhibition.

Biocca S, Iacovelli F, Matarazzo S, Vindigni G, Oteri F, Desideri A, Falconi M.

Cell Cycle. 2015;14(10):1583-95. doi: 10.1080/15384101.2015.1026486.

10.

Therapeutic application of intrabodies against age-related neurodegenerative disorders.

Cardinale A, Merlo D, Giunchedi P, Biocca S.

Curr Pharm Des. 2014;20(38):6028-36. Review.

PMID:
24641233
11.

Simulative and experimental investigation on the cleavage site that generates the soluble human LOX-1.

Biocca S, Arcangeli T, Tagliaferri E, Testa B, Vindigni G, Oteri F, Giorgi A, Iacovelli F, Novelli G, Desideri A, Falconi M.

Arch Biochem Biophys. 2013 Dec;540(1-2):9-18. doi: 10.1016/j.abb.2013.10.001. Epub 2013 Oct 7.

PMID:
24113299
12.

Gene-based antibody strategies for prion diseases.

Cardinale A, Biocca S.

Int J Cell Biol. 2013;2013:710406. doi: 10.1155/2013/710406. Epub 2013 Aug 21. Review.

13.

Design of a novel LOX-1 receptor antagonist mimicking the natural substrate.

Falconi M, Ciccone S, D'Arrigo P, Viani F, Sorge R, Novelli G, Patrizi P, Desideri A, Biocca S.

Biochem Biophys Res Commun. 2013 Aug 23;438(2):340-5. doi: 10.1016/j.bbrc.2013.07.073. Epub 2013 Jul 26.

PMID:
23892036
14.

Cholesterol-lowering drugs inhibit lectin-like oxidized low-density lipoprotein-1 receptor function by membrane raft disruption.

Matarazzo S, Quitadamo MC, Mango R, Ciccone S, Novelli G, Biocca S.

Mol Pharmacol. 2012 Aug;82(2):246-54. doi: 10.1124/mol.112.078915. Epub 2012 May 8.

15.

Altered intracellular distribution of PrPC and impairment of proteasome activity in tau overexpressing cortical neurons.

Canu N, Filesi I, Pristerà A, Ciotti MT, Biocca S.

J Alzheimers Dis. 2011;27(3):603-13. doi: 10.3233/JAD-2011-110446.

PMID:
21841253
16.

LOX-1 as a natural IFN-alpha-mediated signal for apoptotic cell uptake and antigen presentation in dendritic cells.

Parlato S, Romagnoli G, Spadaro F, Canini I, Sirabella P, Borghi P, Ramoni C, Filesi I, Biocca S, Gabriele L, Belardelli F.

Blood. 2010 Feb 25;115(8):1554-63. doi: 10.1182/blood-2009-07-234468. Epub 2009 Dec 15.

18.

Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity.

Biocca S, Falconi M, Filesi I, Baldini F, Vecchione L, Mango R, Romeo F, Federici G, Desideri A, Novelli G.

PLoS One. 2009;4(2):e4648. doi: 10.1371/journal.pone.0004648. Epub 2009 Feb 27.

19.

The potential of intracellular antibodies for therapeutic targeting of protein-misfolding diseases.

Cardinale A, Biocca S.

Trends Mol Med. 2008 Sep;14(9):373-80. doi: 10.1016/j.molmed.2008.07.004. Epub 2008 Aug 5. Review.

PMID:
18693139
20.

Combating protein misfolding and aggregation by intracellular antibodies.

Cardinale A, Biocca S.

Curr Mol Med. 2008 Feb;8(1):2-11. Review.

PMID:
18289010
21.

The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization.

Biocca S, Filesi I, Mango R, Maggiore L, Baldini F, Vecchione L, Viola A, Citro G, Federici G, Romeo F, Novelli G.

J Mol Cell Cardiol. 2008 Mar;44(3):561-70. doi: 10.1016/j.yjmcc.2007.11.017. Epub 2007 Dec 7.

PMID:
18191942
22.
23.
24.

KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity.

Vetrugno V, Cardinale A, Filesi I, Mattei S, Sy MS, Pocchiari M, Biocca S.

Biochem Biophys Res Commun. 2005 Dec 30;338(4):1791-7. Epub 2005 Nov 2.

PMID:
16288721
25.

Alterations of nuclear envelope and chromatin organization in mandibuloacral dysplasia, a rare form of laminopathy.

Filesi I, Gullotta F, Lattanzi G, D'Apice MR, Capanni C, Nardone AM, Columbaro M, Scarano G, Mattioli E, Sabatelli P, Maraldi NM, Biocca S, Novelli G.

Physiol Genomics. 2005 Oct 17;23(2):150-8. Epub 2005 Jul 26.

26.

In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction.

Mango R, Biocca S, del Vecchio F, Clementi F, Sangiuolo F, Amati F, Filareto A, Grelli S, Spitalieri P, Filesi I, Favalli C, Lauro R, Mehta JL, Romeo F, Novelli G.

Circ Res. 2005 Jul 22;97(2):152-8. Epub 2005 Jun 23.

PMID:
15976314
27.

Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation.

Cardinale A, Filesi I, Vetrugno V, Pocchiari M, Sy MS, Biocca S.

J Biol Chem. 2005 Jan 7;280(1):685-94. Epub 2004 Oct 28.

28.

Intracellular targeting and functional analysis of single-chain Fv fragments in mammalian cells.

Cardinale A, Filesi I, Mattei S, Biocca S.

Methods. 2004 Oct;34(2):171-8.

PMID:
15312670
29.

Evidence for proteasome dysfunction in cytotoxicity mediated by anti-Ras intracellular antibodies.

Cardinale A, Filesi I, Mattei S, Biocca S.

Eur J Biochem. 2003 Aug;270(16):3389-97.

30.

Re: Blocking oncogenic Ras signaling for cancer therapy.

Canevari S, Biocca S, Figini M.

J Natl Cancer Inst. 2002 Jul 3;94(13):1031-2; author reply 1032. No abstract available.

PMID:
12096090
31.

Loss of heterochromatin protein 1 (HP1) chromodomain function in mammalian cells by intracellular antibodies causes cell death.

Filesi I, Cardinale A, van der Sar S, Cowell IG, Singh PB, Biocca S.

J Cell Sci. 2002 May 1;115(Pt 9):1803-13.

32.
33.

Diverting a protein from its cellular location by intracellular antibodies. The case of p21Ras.

Lener M, Horn IR, Cardinale A, Messina S, Nielsen UB, Rybak SM, Hoogenboom HR, Cattaneo A, Biocca S.

Eur J Biochem. 2000 Feb;267(4):1196-205.

34.

The selection of intracellular antibodies.

Cattaneo A, Biocca S.

Trends Biotechnol. 1999 Mar;17(3):115-21. Review.

PMID:
10189716
35.

The mode of action of Y13-259 scFv fragment intracellularly expressed in mammalian cells.

Cardinale A, Lener M, Messina S, Cattaneo A, Biocca S.

FEBS Lett. 1998 Nov 20;439(3):197-202.

36.

Assembled IgG molecules are exported from the endoplasmic reticulum in myeloma cells despite the retention signal SEKDEL.

Biocca S, Tafani M, Cattaneo A.

Biochem Biophys Res Commun. 1998 May 19;246(2):518-23.

PMID:
9610394
38.

Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria.

Biocca S, Ruberti F, Tafani M, Pierandrei-Amaldi P, Cattaneo A.

Biotechnology (N Y). 1995 Oct;13(10):1110-5.

PMID:
9636285
39.

Intracellular immunization: antibody targeting to subcellular compartments.

Biocca S, Cattaneo A.

Trends Cell Biol. 1995 Jun;5(6):248-52. No abstract available.

PMID:
14732130
40.

The S-100: a protein family in search of a function.

Fanò G, Biocca S, Fulle S, Mariggiò MA, Belia S, Calissano P.

Prog Neurobiol. 1995 May;46(1):71-82. Review.

PMID:
7568910
41.

Intracellular immunization with cytosolic recombinant antibodies.

Biocca S, Pierandrei-Amaldi P, Campioni N, Cattaneo A.

Biotechnology (N Y). 1994 Apr;12(4):396-9.

PMID:
7764686
42.

Intracellular expression of anti-p21ras single chain Fv fragments inhibits meiotic maturation of xenopus oocytes.

Biocca S, Pierandrei-Amaldi P, Cattaneo A.

Biochem Biophys Res Commun. 1993 Dec 15;197(2):422-7.

PMID:
8267576
43.

'Phytoantibodies': a general vector for the expression of immunoglobulin domains in transgenic plants.

Benvenuto E, Ordàs RJ, Tavazza R, Ancora G, Biocca S, Cattaneo A, Galeffi P.

Plant Mol Biol. 1991 Oct;17(4):865-74.

PMID:
1717050
44.

Neuroantibodies: molecular cloning of a monoclonal antibody against substance P for expression in the central nervous system.

Piccioli P, Ruberti F, Biocca S, Di Luzio A, Werge TM, Bradbury A, Cattaneo A.

Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5611-5.

45.

Intracellular immunization: Expression of antibody domains in the cytoplasm and in the nucleus of mammalian cells.

Biocca S, Di Luzio A, Werge T, Cattaneo A.

Cytotechnology. 1991 Feb;5(Suppl 1):49-50. doi: 10.1007/BF00736806. No abstract available.

PMID:
22358952
46.

Intracellular immunization: expression of antibody domains in the cytoplasm and in the nucleus of mammalian cells.

Biocca S, Di Luzio A, Werge T, Cattaneo A.

Cytotechnology. 1991;5 Suppl 1:49-50. No abstract available.

PMID:
1367119
47.
48.

Expression and targeting of intracellular antibodies in mammalian cells.

Biocca S, Neuberger MS, Cattaneo A.

EMBO J. 1990 Jan;9(1):101-8.

49.

The mode of action of nerve growth factor in PC12 cells.

Levi A, Biocca S, Cattaneo A, Calissano P.

Mol Neurobiol. 1988 Fall;2(3):201-26. Review.

PMID:
2855794
50.

Supplemental Content

Loading ...
Support Center